Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Egfr-in-1 Tfa | 2753348-63-7 | 99.4% | 628.60 | 5 MG
SDP

Catalog No. 5000401203
Encompass_Preferred

EGFR-IN-1 TFA is an orally active and irreversible L858R/T790M mutant selective EGFR inhibitor. It potently inhibits Gefitinib-resistant EGFR L858R, T790M with 100-fold selectivity over wild-type EGFR. It exhibits strong antiproliferative activity against H1975 cells and the first-line mutant HCC827 cells, demonstrating antitumor activity.

  • Potently inhibits Gefitinib-resistant EGFR L858R, T790M
  • 100-fold selectivity over wild-type EGFR
  • Strong antiproliferative activity against H1975 cells and HCC827 cells
  • Antitumor activity demonstrated in vivo

Catalog No. 50-004-01203 Supplier Medchemexpress LLC Supplier No. HY19617B5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

EGFR-IN-1 TFA is an orally active and irreversible L858R/T790M mutant selective EGFR inhibitor. It potently inhibits Gefitinib-resistant EGFR L858R, T790M with 100-fold selectivity over wild-type EGFR. It exhibits strong antiproliferative activity against H1975 cells and the first-line mutant HCC827 cells, demonstrating antitumor activity.

  • Potently inhibits Gefitinib-resistant EGFR L858R, T790M
  • 100-fold selectivity over wild-type EGFR
  • Strong antiproliferative activity against H1975 cells and HCC827 cells
  • Antitumor activity demonstrated in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.